Javascript must be enabled to continue!
Neuroblastoma in Children: Intraoperative Goal Directed Therapy, Intraoperative And Postoperative Outcomes
View through CrossRef
Abstract
Background: Neuroblastoma is the most common tumor in children. Anesthetic management can be challenging due to the localization and catecholamine-secreting characteristics of the tumor. We undertook a secondary analysis in a previous study to describe patients who underwent neuroblastoma resection.Objective: To describe intraoperative and postoperative outcomes in patients who underwent neuroblastoma resection and to propose optimal intraoperative management for postoperative outcome improvement.Methods: This was a secondary analysis of children who underwent neuroblastoma resection in the initial retrospective study.Results: There were 16 patients with a mean age of 39.3±22.1 months. Seven (43.8%) patients presented with intraoperative or postoperative complications. One (6.3%) patient had intraoperative broncholaryngospasm and difficult intubation. Two (12.5%) patients had intraoperative hemorrhagic shock. One patient (6.3%) had postoperative renal failure. Two patients (12.5%) had postoperative respiratory failure, and 3 (18.8%) patients had postoperative cardiocirculatory failure. One (6.3%) had postoperative pulmonary sepsis and septicemia. Thirteen (81.3%) patients were intraoperatively transfused. There was no in-hospital mortality.Conclusion: Neuroblastoma surgery can be a challenging situation where cardiovascular instability, high blood loss and transfusion requirements can be encountered. Consequently, preoperative preparation and optimal intraoperative management with validated means in children are necessary for a better postoperative outcome in this surgical setting.
Title: Neuroblastoma in Children: Intraoperative Goal Directed Therapy, Intraoperative And Postoperative Outcomes
Description:
Abstract
Background: Neuroblastoma is the most common tumor in children.
Anesthetic management can be challenging due to the localization and catecholamine-secreting characteristics of the tumor.
We undertook a secondary analysis in a previous study to describe patients who underwent neuroblastoma resection.
Objective: To describe intraoperative and postoperative outcomes in patients who underwent neuroblastoma resection and to propose optimal intraoperative management for postoperative outcome improvement.
Methods: This was a secondary analysis of children who underwent neuroblastoma resection in the initial retrospective study.
Results: There were 16 patients with a mean age of 39.
3±22.
1 months.
Seven (43.
8%) patients presented with intraoperative or postoperative complications.
One (6.
3%) patient had intraoperative broncholaryngospasm and difficult intubation.
Two (12.
5%) patients had intraoperative hemorrhagic shock.
One patient (6.
3%) had postoperative renal failure.
Two patients (12.
5%) had postoperative respiratory failure, and 3 (18.
8%) patients had postoperative cardiocirculatory failure.
One (6.
3%) had postoperative pulmonary sepsis and septicemia.
Thirteen (81.
3%) patients were intraoperatively transfused.
There was no in-hospital mortality.
Conclusion: Neuroblastoma surgery can be a challenging situation where cardiovascular instability, high blood loss and transfusion requirements can be encountered.
Consequently, preoperative preparation and optimal intraoperative management with validated means in children are necessary for a better postoperative outcome in this surgical setting.
Related Results
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Radical prostatectomy is the most commonly performed treatment option for localised prostate cancer. In the last decades the surgical technique has been improved and modified in or...
Data from SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in Neuroblastoma
Data from SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in Neuroblastoma
<div>Abstract<p>Survival rates among patients with high-risk neuroblastoma remain low and novel therapies for recurrent neuroblastomas are required. <i>ALK</i&...
Data from SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in Neuroblastoma
Data from SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in Neuroblastoma
<div>Abstract<p>Survival rates among patients with high-risk neuroblastoma remain low and novel therapies for recurrent neuroblastomas are required. <i>ALK</i&...
Abstract 4758: Inhibition of checkpoint kinase 1 (Chk1) as a potential therapeutic for pediatric neuroblastoma
Abstract 4758: Inhibition of checkpoint kinase 1 (Chk1) as a potential therapeutic for pediatric neuroblastoma
Abstract
Neuroblastoma is a cancer derived from cells of the sympathetic nervous system that manifests with significant clinical heterogeneity. Although children dia...
Family Pediatrics
Family Pediatrics
ABSTRACT/EXECUTIVE SUMMARYWhy a Task Force on the Family?The practice of pediatrics is unique among medical specialties in many ways, among which is the nearly certain presence of ...
Abstract 6449: Unique site-specific phosphorylation of PML co-ordinates disease aggravation of neuroblastoma
Abstract 6449: Unique site-specific phosphorylation of PML co-ordinates disease aggravation of neuroblastoma
Abstract
Neuroblastoma a fatal infant malignancy accounts for 15% of pediatric cancer deaths. The standard treatment for children with neuroblastoma is intensive and...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

